All Stories

  1. Ultrasound-guided renal artery administration of angiopoietin-1 RNA therapy slows the progression of preclinical WT1 glomerular disease
  2. Response to the Letter to the Editor Entitled “Revisiting Vincristine for FSGS: Proof-of-Mechanism Arrives, but Whom Should we Treat?”
  3. Letter to the Editor re: Genomic testing in paediatric urology: implications for diagnosis and management
  4. A simple technique to create pre-vascularised delivery scaffolds for organoid therapies
  5. Vincristine Treatment Protects Against Podocyte Damage in Focal Segmental Glomerulosclerosis
  6. Nanobody Immunolabelling and three-dimensional imaging reveals spatially restricted LYVE1 expression by kidney lymphatic vessels in mice
  7. A cross model spatial and single-cell atlas reveals the conserved involvement of osteopontin in polycystic kidney disease
  8. Mapping the arterial vascular network in an intact human kidney using hierarchical phase-contrast tomography
  9. Neurite outgrowth inhibitor-B (Nogo-B) in physiology and disease.
  10. Genetic lineage tracing identifies intermediate mesoderm as a novel contributor to mammalian kidney lymphatics
  11. Organ-specific features of human kidney lymphatics are disrupted in chronic transplant rejection
  12. Microvascular aberrations found in human polycystic kidneys are an early feature in a Pkd1 mutant mouse model
  13. Reduction of elevated Gli3 does not alter the progression of autosomal recessive polycystic kidney disease
  14. Vincristine treatment reverses podocyte damage in focal segmental glomerulosclerosis
  15. Reversal of elevatedGli3in Autosomal Recessive Polycystic Kidney Disease does not alter cystogenesis
  16. Cell Catcher: A New Method to Extract and Preserve Live Renal Cells from Urine
  17. Single‐cell transcriptomics identifies aberrant glomerular angiogenic signalling in the early stages of WT1 kidney disease
  18. SGLT1 contributes to glucose-mediated exacerbation of ischemia–reperfusion injury in ex vivo rat heart
  19. Cardiotrophin‐1 therapy reduces disease severity in a murine model of glomerular disease
  20. A unique subset of pericystic endothelium associates with aberrant microvascular remodelling and impaired blood perfusion early in polycystic kidney disease
  21. A microfluidic platform integrating functional vascularized organoids-on-chip
  22. Cell Catcher: a new method to extract and preserve live renal cells from urine
  23. Mapping the blood vasculature in an intact human kidney using hierarchical phase-contrast tomography
  24. Hyperglycemic exacerbation of myocardial infarction through SGLT1 - a glucose paradox
  25. Three-dimensional imaging and single-cell transcriptomics of the human kidney implicate perturbation of lymphatics in alloimmunity
  26. Systemic gene therapy with thymosin β4 alleviates glomerular injury in mice
  27. The timing of auditory sensory deficits in Norrie disease has implications for therapeutic intervention
  28. ­­­Kidney organoids recapitulate human basement membrane assembly in health and disease
  29. Imaging intact human organs with local resolution of cellular structures using hierarchical phase-contrast tomography
  30. Experimental long-term diabetes mellitus alters the transcriptome and biomechanical properties of the rat urinary bladder
  31. Identification of an Altered Matrix Signature in Kidney Aging and Disease
  32. Systemic gene therapy with thymosin β4 alleviates glomerular injury in mice
  33. Mechanisms and cell lineages in lymphatic vascular development
  34. The Biological Significance and Implications of Planar Cell Polarity for Nephrology
  35. Multiscale three-dimensional imaging of intact human organs down to the cellular scale using hierarchical phase-contrast tomography
  36. Antenatal biological models in the characterization and research of congenital lower urinary tract disorders
  37. Endothelial-epithelial communication in polycystic kidney disease: Role of vascular endothelial growth factor signalling
  38. Pseudouridylation defect due to DKC1 and NOP10 mutations causes nephrotic syndrome with cataracts, hearing impairment, and enterocolitis
  39. Beyond a Passive Conduit: Implications of Lymphatic Biology for Kidney Diseases
  40. Free 25-hydroxyvitamin-D concentrations are lower in children with renal transplant compared with chronic kidney disease
  41. Spatiotemporal dynamics and heterogeneity of renal lymphatics in mammalian development and cystic kidney disease
  42. Generating Mutant Renal Cell Lines Using CRISPR Technologies
  43. Tissue Clearing and Deep Imaging of the Kidney Using Confocal and Two-Photon Microscopy
  44. Overexpression of Circulating Soluble Nogo-B Improves Diabetic Kidney Disease by Protecting the Vasculature
  45. Arterial “inflammaging” drives vascular calcification in children on dialysis
  46. SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in the Diabetic and Nondiabetic Heart
  47. Planar cell polarity in organ formation
  48. Vangl2, a planar cell polarity molecule, is implicated in irreversible and reversible kidney glomerular injury
  49. In vivo three-dimensional photoacoustic imaging of the renal vasculature in preclinical rodent models
  50. Thymosin-β4: A key modifier of renal disease
  51. Lithium induces mesenchymal-epithelial differentiation during human kidney development by activation of the Wnt signalling system
  52. HeterozygousVangl2Looptailmice reveal novel roles for the planar cell polarity pathway in adult lung homeostasis and repair
  53. Planar cell polarity genes Celsr1 and Vangl2 are necessary for kidney growth, differentiation, and rostrocaudal patterning
  54. Vascular growth factors play critical roles in kidney glomeruli
  55. The role of thymosin-β4 in kidney disease
  56. Vascular Endothelial Growth Factor C for Polycystic Kidney Diseases
  57. HDL in Children with CKD Promotes Endothelial Dysfunction and an Abnormal Vascular Phenotype
  58. Planar cell polarity and the kidney
  59. Targeted Glomerular Angiopoietin-1 Therapy for Early Diabetic Kidney Disease
  60. Albuminuria is associated with too few glomeruli and too much testosterone
  61. Circulating Angiopoietin-2 Is a Marker for Early Cardiovascular Disease in Children on Chronic Dialysis
  62. Mechanistic Insights into Vascular Calcification in CKD
  63. Angiogenesis and autosomal dominant polycystic kidney disease
  64. The renal archaeologist: digging for clues in archived tissues to understand diabetic kidney disease
  65. Restoring the renal microvasculature to treat chronic kidney disease
  66. An unusual case of pediatric shortness of breath—questions
  67. Selective Stimulation of VEGFR2 Accelerates Progressive Renal Disease
  68. Modified Citrus Pectin Reduces Galectin-3 Expression and Disease Severity in Experimental Acute Kidney Injury
  69. The planar cell polarity gene Vangl2 is required for mammalian kidney-branching morphogenesis and glomerular maturation
  70. Mutations in HPSE2 Cause Urofacial Syndrome
  71. Corticosteroid-induced kidney dysmorphogenesis is associated with deregulated expression of known cystogenic molecules, as well as indian hedgehog
  72. Sphingosine kinase-1: a potential mediator of renal fibrosis
  73. Abnormal Angiogenesis in Diabetic Nephropathy
  74. Unraveling the Genetic Landscape of Bladder Development in Mice
  75. HNF1BMutations Associate with Hypomagnesemia and Renal Magnesium Wasting
  76. Angiostatin overexpression is associated with an improvement in chronic kidney injury by an anti-inflammatory mechanism
  77. Roles of Angiopoietins in Kidney Development and Disease: Figure 1.
  78. Teashirt 3 is necessary for ureteral smooth muscle differentiation downstream of SHH and BMP4
  79. Angiopoietin-1 therapy enhances fibrosis and inflammation following folic acid-induced acute renal injury
  80. Podocyte-Specific Expression of Angiopoietin-2 Causes Proteinuria and Apoptosis of Glomerular Endothelia
  81. Microarray interrogation of human metanephric mesenchymal cells highlights potentially important molecules in vivo
  82. Vascular endothelial growth factor administration does not improve microvascular disease in the salt-dependent phase of post-angiotensin II hypertension
  83. Experimental short-term fetal bladder outflow obstruction: I. Morphology and cell biology associated with urinary flow impairment
  84. Vascular endothelial growth factor stimulates embryonic urinary bladder development in organ culture
  85. Human Vascular Smooth Muscle Cells Express a Urate Transporter
  86. Loss of nitric oxide and endothelial-derived hyperpolarizing factor-mediated responses in aging
  87. IL-10 Suppresses Chemokines, Inflammation, and Fibrosis in a Model of Chronic Renal Disease
  88. How Does Angiotensin II Cause Renal Injury?
  89. Angiopoietin correlates with glomerular capillary loss in anti-glomerular basement membrane glomerulonephritis